Billionaires Are Buying Up Beaten-Down Pfizer Stock. Should You Follow Their Lead?

Nobody can predict the future, but it's not hard to imagine increasing pharmaceutical sales. In 2022, prescription drug spending in the U.S. climbed more than 8% to reach $406 billion. It's a lot but still less than one-third of the amount soaked up by American hospitals. It might not feel like it when you pay the bill, but prescription drugs give healthcare systems a tremendous return on their investment. With this in mind, it's no wonder billionaires are buying up shares of one of America's largest pharma ...